OOIR: Observatory of International Research

Papers

(The H4-Index of Seminars in Immunology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Learning from Inborn Errors of Immunity: From mechanisms to translation	121
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells	93
Editorial Board	92
Durability of immune responses to SARS-CoV-2 infection and vaccination	80
Editorial Board	70
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases	69
Microbial gasdermins: More than a billion years of pyroptotic-like cell death	66
Toolkit for mapping the clonal landscape of tumor-infiltrating B cells	60
Thymus aging and immune reconstitution, progresses and challenges	50
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities	50
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy	49
Exploiting antifungal immunity in the clinical context	49
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS	47
Recent developments in C3-targeted complement therapeutics	46
The origins, manifestations, and potential treatments of allergic disorders	45
Sialic acid and Siglec receptors in tumor immunity and immunotherapy	37
Versatile neutrophil functions in cancer	37
T cell immunity to SARS-CoV-2	36
Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients	36
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel	35
Systems biology of B cells in COVID-19	35
B cells and the intestinal microbiome in time, space and place	35
Formyl peptide receptor 2 and heart disease	34
The role of unconventional T cells in maintaining tissue homeostasis	34
Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology	33

High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions	33
Antigen discovery for the development of cancer immunotherapy	32
The role of ILC subsets in cancer	32
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer	31
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls	30